Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity

Chan Cheah, LJ Nastoupil, P McLaughlin, MA Fanale, SS Neelapu, LE Fayad, FB Hagemeister, NH Fowler

    Research output: Contribution to journalLetter

    7 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)531-533
    Number of pages3
    JournalBritish Journal of Haematology
    Issue number3
    Publication statusPublished - 1 Nov 2016

    Cite this